Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-FR
Language French French
Date Updated 2017-08-15 2017-06-30
Drug Identification Number 02236606 02236606
Brand name ACCOLATE TAB 20 MG ACCOLATE TAB 20 MG
Common or Proper name zafirlukast tablets zafirlukast tablets
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients ZAFIRLUKAST ZAFIRLUKAST
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60 60
ATC code R03DC R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-12-31 2017-12-31
Actual start date
Estimated end date Unknown Unknown
Actual end date 2017-08-15
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments